CORRESP 1 filename1.htm

 

December 11, 2006

VIA EDGAR

Mr. Craig D. Wilson
Senior Assistant Chief Accountant
Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549

Re:                               Form 8-K filed March 1, 2006
File No. 0-13063                                                                                   

Dear Mr. Wilson:

Reference is made to the letter dated December 1, 2006 (the “Comment Letter”) from the Staff of the Division of Corporation Finance to Mr. A. Lorne Weil, Chief Executive Officer of Scientific Games Corporation (the “Company”), setting forth the Staff’s comment regarding the filing referenced above.  Accordingly, this letter contains the Company’s responses to the Staff’s comments in the Comment Letter.  The paragraph numbers of the Company’s responses correspond to the numbers appearing next to the Staff’s comments as set forth in the Comment Letter.

We are also sending you a copy of this letter by Federal Express.

Very truly yours,

 

 

 

/s/ DeWayne E. Laird

 

DeWayne E. Laird

 

Vice President and Chief Financial Officer

 

cc:                                 Mr. A. Lorne Weil
  Chief Executive Officer
  Scientific Games Corporation




Form 8-K, filed March 1, 2006

Item 2.02 Results of Operations and Financial Condition

1.               We note your response to prior comment 1 and have the following additional comments:

a)              With regard to item 1, you indicate that you identified certain adjustments in the fourth quarter of 2004 in connection with your initial Sarbanes-Oxley review.  Please clarify the period(s) to which these adjustments relate.  We note that in your other responses you indicate that charges were incurred, rather than identified, in the 4th quarter.

Response:

A portion ($1,522,000 in the aggregate on a pre tax basis) of the adjustments that were identified in the fourth quarter of 2004 as part of our initial Sarbanes-Oxley review relate to earlier periods.   We have provided as Appendix I a chart which provides a summary of the prior periods impacted by these adjustments.

b)             With regard to item 3, you indicate that you recorded your share of the Italian consortium’s loss for the year 2004 in the fourth quarter of 2004.  We further note from your response related to item 8 that you recorded your share of Italian consortium’s fourth quarter 2005 loss in the fourth quarter of 2005.  Please explain why you recorded the loss for the full year 2004 in the fourth quarter of 2004.

Response:

During 2004, the Company held a minority equity interest in an incorporated Italian consortium (which was formed in 2003 and began operations in 2004) that was accounted for under the cost method of accounting during the year.  Subsequent to year end, management determined that because the Company had a 20% equity interest in an entity of that type, the Company should have been recognizing its pro-rata share of losses of the consortium in 2004 using the equity method of accounting.

Had the Company recorded its quarterly pro-rata share of the losses of the consortium from its inception, the Company would have recorded net losses in the interim periods of 2004 as shown on Appendix I.

As to the matters addressed in both a) and b) above, we performed a SAB 99 analysis of the adjustments identified in connection with our initial Sarbanes-Oxley review and the Italian consortium adjustments and concluded that these amounts were not quantitatively material either individually or in the aggregate to consolidated net income or net income per diluted share available to common stockholders or to gross profit or operating income for any of the affected interim or annual periods (See Appendix I).   In assessing the quantitative materiality of these adjustments, we followed the guidance in paragraph 29 of APB 28 Interim Financial Reporting.




We also concluded that these items were not qualitatively material based on the following considerations:

·                  The items did not change the earnings trend of the Company, or in the case of the items identified in connection with our initial Sarbanes-Oxley review, the earnings trend of the Pari-Mutuel Segment (which was negative even absent these items), to which such adjustments relate.  Our share of the Italian consortium losses were not included in any segment since those losses were not included in operating income;

·                  The items did not change a loss into income or vice versa;

·                  The items did not affect the Company’s regulatory compliance;

·                  The items did not affect the Company’s compliance with loan covenants or other contractual requirements;

·                  The items identified in connection with our initial Sarbanes-Oxley review had the effect of increasing the bonus compensation for the Pari-Mutuel segment managers by a total of $17,000 for all concerned in 2003; however, they had no effect on the overall corporate bonus awards.  The Italian consortium losses did not increase any bonus compensation;

·                  The items did not arise from an unlawful transaction and there was no indication of any overt action taken by management to manipulate earnings to meet consensus earnings estimates.

Therefore, we concluded that it was acceptable to record these items in the fourth quarter of 2004.

We have discussed these matters with our audit committee and our independent auditor, Deloitte & Touche LLP, both of which concurred with our conclusions.




 

APPENDIX 1

Scientific Games Corporation

SAB 99 Analysis - 2002, 2003 and 2004

 

 

 

Year

 

Quarter

 

Year

 

 

 

 

 

 

 

 

 

Year

 

 

 

Ended

 

Ended

 

Ended

 

Quarter Ended

 

Ended

 

 

 

2002

 

Dec-03

 

2003

 

Mar-04

 

Jun-04

 

Sep-04

 

Dec-04

 

2004

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating revenues

 

455,253

 

176,781

 

560,911

 

185,465

 

178,112

 

179,309

 

182,609

 

725,495

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

39,732

 

15,019

 

52,147

 

20,421

 

19,508

 

21,461

 

4,352

 

65,742

 

Convertible preferred stock dividend

 

7,484

 

1,977

 

7,661

 

1,982

 

1,982

 

757

 

 

4,721

 

Net income available to common stockholders, as reported

 

32,248

 

13,042

 

44,486

 

18,439

 

17,526

 

20,704

 

4,352

 

61,021

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Italian consortium

 

 

 

 

751

 

1,644

 

1,427

 

(3,822

)

 

 Sarbanes-Oxley review

 

149

 

884

 

884

 

135

 

75

 

279

 

(1,522

)

(1,033

)

Total adjustments

 

149

 

884

 

884

 

886

 

1,719

 

1,706

 

(5,344

)

(1,033

)

Tax effect

 

(54

)

(318

)

(318

)

(279

)

(541

)

(529

)

1,630

 

315

 

Net income effect of adjustments

 

95

 

566

 

566

 

607

 

1,178

 

1,177

 

(3,714

)

(718

)

Pro forma net income, giving effect to the adjustments

 

39,637

 

14,453

 

51,581

 

19,814

 

18,330

 

20,284

 

8,066

 

66,460

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share, as reported

 

0.496

 

0.165

 

0.592

 

0.222

 

0.215

 

0.236

 

0.048

 

0.724

 

Pro forma diluted earnings per share, giving effect to the adjustments

 

0.495

 

0.159

 

0.585

 

0.216

 

0.202

 

0.223

 

0.088

 

0.733

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income effect of adjustments as a percentage of:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

0.3

%

4.3

%

1.3

%

3.3

%

6.7

%

5.7

%

-85.3

%

-1.2

%

Diluted earnings per share

 

0.2

%

3.8

%

1.1

%

3.0

%

6.0

%

5.5

%

-83.7

%

-1.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted shares

 

80,151

 

90,914

 

88,143

 

91,825

 

90,757

 

90,777

 

91,463

 

90,710

 

 

 

Notes:

The impact of the adjustments on gross margin and operating income is no greater than the impact on net income or earnings per share in any of the periods impacted.